vipadenant [Ligand Id: 5612] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL447664 (Biib014, BIIB-014, BIIB014, CEB-4520, V-2006, V2006, VER-11135, VER-A-00049, VER-A00049, VER-A-00-11, VER-A00-11, VER-ADO-49, Vipadenant)
  • A1 receptor/Adenosine A1 receptor in Human [ChEMBL: CHEMBL226] [GtoPdb: 18] [UniProtKB: P30542]
There should be some charts here, you may need to enable JavaScript!
  • A2A receptor/Adenosine A2a receptor in Human [ChEMBL: CHEMBL251] [GtoPdb: 19] [UniProtKB: P29274]
There should be some charts here, you may need to enable JavaScript!
  • A2B receptor/Adenosine A2b receptor in Human [ChEMBL: CHEMBL255] [GtoPdb: 20] [UniProtKB: P29275]
There should be some charts here, you may need to enable JavaScript!
  • A3 receptor/Adenosine A3 receptor in Human [ChEMBL: CHEMBL256] [GtoPdb: 21] [UniProtKB: P0DMS8]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
A1 receptor/Adenosine A1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL226] [GtoPdb: 18] [UniProtKB: P30542]
ChEMBL Antagonist activity at human adenosine A1 receptor expressed in CHO-K1 cells by calcium mobilization-based FLIPR assay F 7 pKd 100 nM Kd J Med Chem (2009) 52: 33-47 [PMID:19072055]
ChEMBL Displacement of radioligand from human recombinant adenosine A1 receptor at 21 degC after 90 mins by cell-based microplate scintillation counting B 7.17 pKi 68 nM Ki J Med Chem (2009) 52: 33-47 [PMID:19072055]
ChEMBL Inhibition of human recombinant adenosine A1 receptor B 7.17 pKi 68 nM Ki J Med Chem (2014) 57: 3623-3650 [PMID:24164628]
GtoPdb - - 7.17 pKi 68 nM Ki J Med Chem (2009) 52: 33-47 [PMID:19072055]
A2A receptor/Adenosine A2a receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL251] [GtoPdb: 19] [UniProtKB: P29274]
ChEMBL Antagonist activity at human adenosine A2A receptor expressed in CHO-K1 cells treated for 15 mins by calcium mobilization-based FLIPR assay F 9.2 pKd 0.63 nM Kd J Med Chem (2009) 52: 33-47 [PMID:19072055]
ChEMBL Displacement of radioligand from human recombinant adenosine A2A receptor at 21 degC after 90 mins by cell-based microplate scintillation counting B 8.89 pKi 1.3 nM Ki J Med Chem (2009) 52: 33-47 [PMID:19072055]
ChEMBL Inhibition of human recombinant adenosine receptor A2a F 8.89 pKi 1.3 nM Ki J Med Chem (2014) 57: 3623-3650 [PMID:24164628]
GtoPdb - - 8.89 pKi 1.3 nM Ki J Med Chem (2009) 52: 33-47 [PMID:19072055]
A2B receptor/Adenosine A2b receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL255] [GtoPdb: 20] [UniProtKB: P29275]
ChEMBL Antagonist activity at human adenosine A2B receptor expressed in CHO-K1 cells by calcium mobilization-based FLIPR assay F 7.5 pKd 31.62 nM Kd J Med Chem (2009) 52: 33-47 [PMID:19072055]
GtoPdb - - 7.2 pKi 63 nM Ki J Med Chem (2009) 52: 33-47 [PMID:19072055]
ChEMBL Displacement of radioligand from human recombinant adenosine A2B receptor at 21 degC after 60 mins by cell-based microplate scintillation counting B 7.2 pKi 63 nM Ki J Med Chem (2009) 52: 33-47 [PMID:19072055]
ChEMBL Inhibition of human recombinant adenosine receptor A2b B 7.2 pKi 63 nM Ki J Med Chem (2014) 57: 3623-3650 [PMID:24164628]
A3 receptor/Adenosine A3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL256] [GtoPdb: 21] [UniProtKB: P0DMS8]
ChEMBL Antagonist activity at human adenosine A3 receptor expressed in CHO-K1 cells by calcium mobilization-based FLIPR assay F 5.8 pKd 1584.89 nM Kd J Med Chem (2009) 52: 33-47 [PMID:19072055]
ChEMBL Displacement of radioligand from human recombinant adenosine A3 receptor at 21 degC after 60 mins by cell-based microplate scintillation counting B 6 pKi 1005 nM Ki J Med Chem (2009) 52: 33-47 [PMID:19072055]
ChEMBL Inhibition of human recombinant adenosine A3 receptor B 6 pKi 1005 nM Ki J Med Chem (2014) 57: 3623-3650 [PMID:24164628]
GtoPdb - - 6 pKi 1005 nM Ki J Med Chem (2009) 52: 33-47 [PMID:19072055]

ChEMBL data shown on this page come from version 33:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]